56771-74-5

Usage

Uses

Used in Pharmaceutical Industry:
2,5-DIMETHOXYPHENETHYL ISOTHIOCYANATE is used as a potential anti-cancer agent for its ability to inhibit the growth of cancer cells. It has shown promise in experimental studies, making it a candidate for further research and development in cancer treatment.
Used in Anti-inflammatory Applications:
2,5-DIMETHOXYPHENETHYL ISOTHIOCYANATE is used as an anti-inflammatory agent due to its potential to reduce inflammation in experimental studies. This property makes it a candidate for the development of treatments for inflammatory conditions.
Used in Antioxidant Applications:
2,5-DIMETHOXYPHENETHYL ISOTHIOCYANATE is used as an antioxidant, as its antioxidant properties have been investigated in research studies. This characteristic may contribute to its potential therapeutic applications in various health-related areas.

InChI:InChI=1/C11H13NO2S/c1-13-10-3-4-11(14-2)9(7-10)5-6-12-8-15/h3-4,7H,5-6H2,1-2H3

Upstream product

• 40276-11-7 (E)-1,4-dimethoxy-2-(2-nitrovinyl) benzene 
• 93-02-7 2,5-dimethoxybenzaldehyde 
• 75-15-0 carbon disulfide 
• 3600-86-0 2,5-dimethoxyphenethylamine 

Relevant academic research and scientific papers

Design, synthesis and evaluation of thiourea derivatives as antimicrobial and antiviral agents

Background: The development of drug-resistant by bacteria appears rapidly and thus making the effectiveness of antibiotics severely limited. Methods: A series of thiourea derivatives was synthesized, characterized and evaluated for their in vitro antibacterial, antifungal and antiviral activities. Results: Structures of the newly synthesized compounds were confirmed by elemental and spectral analysis. The biological results showed that some of the target compounds displayed comparable antimicrobial and antiviral activities with reference drugs. Structure-activity relationship studies revealed that the ortho-chloro or fluoro substituted phenyl at Ar1 and substituted pyridinyl at Ar2 positions of the thiourea nucleus are essential for their in vitro antimicrobial and anti-HIV activity. In particular, compounds 8 and 10 showed better activity against the tested bacteria, fungi and viral strains than other synthesized PET derivatives reported in the present study. Conclusion: These results provide an encouraging lead that could be used for the development of new potent antiviral and antimicrobial agents.